Preparation method of cyclic phosphonate compound

By converting phosphonic acid compounds into phosphonochlorine intermediates and reacting with propylene glycol in the presence of Lewis acid and base, the synthesis of cyclic phosphonic acid ester compounds is optimized, and the problem of low cis configuration yield is solved, and the Highly efficient and low-toxic drug preparation, suitable for the treatment of non-alcoholic steatohepatitis.

CN118894885APending Publication Date: 2024-11-05GANNEX PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410823703.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2020-02-18
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

In the existing synthesis methods of cyclic phosphonate compounds, the target compound in the cis configuration has a low yield and insufficient stereoselectivity, making it difficult to meet the needs of highly efficient and low-toxic non-alcoholic steatohepatitis drugs.

Method used

The synthesis conditions are optimized to improve the stereoselectivity of the reaction by converting the phosphonic acid compound into a phosphonochlorine intermediate and reacting with propylene glycol in the presence of Lewis acids such as TiCl4, SnCl4 and/or FeCl3 and bases such as TEA. Yield.

Benefits of technology

The stereoselectivity and yield of the target compound is significantly improved, ensuring the efficient preparation of cylindrical phosphonate compounds in the cis configuration, suitable for the treatment of non-alcoholic steatohepatitis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118894885A_ABST
    Figure CN118894885A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of a cyclic phosphonate compound, which comprises the following steps: (1) reacting a compound as shown in a formula 9 with a chlorination reagent to obtain a phosphonyl chloride intermediate 11, and dissolving the phosphonyl chloride intermediate 11 in an organic solvent to obtain a solution of the phosphonyl chloride intermediate 11 for later use; (2) a compound shown in the formula 10 is dissolved in an organic solvent, lewis acid and alkali are sequentially added for a stirring reaction, then the obtained reaction liquid is added into the solution of the phosphonyl chloride intermediate 11 in the step (1) for a reaction, the cyclic phosphonate compound shown in the formula 1 is obtained, and the lewis acid is TiCl4, SnCl4 and / or FeCl3. According to the method disclosed by the invention, the stereoselectivity and the yield of the target compound with the required configuration as shown in the formula 1 can be remarkably improved. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medicinal chemistry, and in particular to a method for preparing a cyclic phosphonate compound. Background Art

[0002] The compound shown in formula 1 (molecular formula: C 28 H 32 ClO5P, molecular weight 514.98, CAS registration number: 852948-13-1) is a cyclic phosphonate compound. As a new oral thyroid hormone beta receptor agonist (THR-betaagonist), it selectively activates THR-β, regulates the gene expression of downstream CYP7A and SREBP-1c, effectively promotes the decomposition of fatty acids and stimulates mitochondrial biogenesis, reduces low-density lipoprotein and triglyceride levels, thereby reducing fat toxicity and improving liver function, reducing liver fat. It is a highly effective and low-toxic candidate drug for nonalcoholic steatohepatitis (NASH).

[0003]

[0004] Patent application WO2006128055 discloses a method for synthesizing a cyclic phosphonate compound, wherein the corresponding phosphonic acid and propylene glycol compounds are reacted in the presence of pyridine and a condensing agent 1,3-dicyclohexylcarbodiimide. When preparing the compound shown in Formula 1, due to the presence of two chiral centers thereon, the above method will prepare compounds of both cis and trans configurations, and the yield of the target compound of the cis configuration is low. Therefore, it is necessary to optimize the synthesis process conditions to improve the stereoselectivity and yield of the compound of the target configuration. Summary of the invention

[0005] Therefore, the object of the present invention is to provide an improved method for preparing the cyclic phosphonate compound of Formula 1, which can improve the stereoselectivity and yield of the reaction to obtain the target compound of Formula 1 with the desired configuration.

[0006] The objectives of the present invention are achieved through the following technical solutions.

[0007] The present invention provides a method for preparing a cyclic phosphonate compound represented by Formula 1, comprising the following steps:

[0008]

[0009] (1) reacting the compound represented by formula 9 with a chlorinating agent to obtain a phosphonyl chloride intermediate 11, which is then dissolved in an organic solvent to obtain a solution of the phosphonyl chloride intermediate 11 for later use;

[0010]

[0011] (2) dissolving the compound represented by formula 10 in an organic solvent, adding a Lewis acid and a base in sequence, stirring and reacting, and then adding the resulting reaction solution to the solution of the phosphonyl chloride intermediate 11 described in step (1) to react, thereby obtaining a cyclic phosphonate compound represented by formula 1, wherein the Lewis acid is TiCl4, SnCl4 and / or FeCl3,

[0012]

[0013] The inventors unexpectedly found that in the process of preparing the cyclic phosphonate compound shown in Formula 1 from the phosphonic acid compound shown in Formula 9, first converting the phosphonic acid compound shown in Formula 9 into a phosphonyl chloride intermediate 11, and then reacting it with a propylene glycol compound shown in Formula 10 in the presence of a Lewis acid (TiCl4, SnCl4 and / or FeCl3) and a base (preferably an organic base such as TEA) can significantly improve the stereoselectivity of the reaction to generate the target compound shown in Formula 1 and improve the reaction yield. However, the use of other Lewis acids, such as AlCl3, is not conducive to the generation of the target compound shown in Formula 1, and the reaction yield is low.

[0014] In certain embodiments of the present invention, the organic solvent is dichloromethane, 1,2-dichloroethane and / or tetrahydrofuran.

[0015] In certain embodiments of the present invention, the chlorinating agent is thionyl chloride, oxalyl chloride and / or triphosgene; preferably, in step (1), the molar ratio of the chlorinating agent to the compound of formula 9 is 2:1 to 5:1.

[0016] In certain embodiments of the present invention, the molar ratio of the compound represented by Formula 10 to the compound represented by Formula 9 in step (2) is 1.0:1 to 1.2:1.

[0017] In certain embodiments of the present invention, the molar ratio of the Lewis acid to the compound represented by Formula 10 is 1:1 to 2:1.

[0018] In certain embodiments of the present invention, the base is an organic base, preferably triethylamine; preferably, the molar ratio of the triethylamine to the compound represented by Formula 10 is 1.5:1 to 8:1.

[0019] In certain embodiments of the present invention, in step (1), the chlorination reagent is added dropwise to the compound represented by formula 9 at 15-25°C, and the reaction is carried out at 35-85°C.

[0020] In certain embodiments of the present invention, in step (1), the compound represented by formula 9 is reacted with the chlorination agent in the presence of N,N-dimethylformamide. Preferably, the molar ratio of the N,N-dimethylformamide to the compound represented by formula 9 is 0.02:1 to 0.5:1.

[0021] In certain embodiments of the present invention, in step (2), the Lewis acid is added dropwise at -10 to 15°C, and the base is added dropwise at -20 to 10°C. Preferably, after the Lewis acid and the base are added in sequence, the reaction is stirred for 10 to 60 minutes.

[0022] In certain embodiments of the present invention, in step (2), the reaction solution is added dropwise to the solution of the phosphonyl chloride intermediate 11 at -50 to 0°C and the reaction is carried out at -50 to 0°C. Preferably, in step (2), the reaction solution is added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40 to -30°C and the reaction is carried out at -40 to -30°C. The inventors unexpectedly found that adding the reaction solution dropwise and carrying out the reaction at -40 to -30°C can further greatly improve the stereoselectivity of obtaining the target compound of the desired configuration and significantly improve the reaction yield.

[0023] The method of the present invention comprises the steps of first converting a phosphonic acid compound into a phosphonyl chloride intermediate, and then reacting the intermediate with a 1,3-propylene glycol compound to prepare a target compound shown in Formula 1, wherein adding Lewis acids TiCl4, SnCl4 and / or FeCl3, and a base such as TEA to the reaction system can significantly improve the stereoselectivity of obtaining the target compound with the desired configuration, and significantly improve the yield of the target compound shown in Formula 1. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] The embodiments of the present invention are described in detail below with reference to the accompanying drawings, wherein:

[0025] Figure 1 The X-ray single crystal diffraction pattern of the compound of formula 1 obtained in the example of the present invention is shown. DETAILED DESCRIPTION

[0026] Example 1

[0027]

[0028] 1. Synthesis of intermediate compound of formula 9

[0029] Synthesis of compound of formula 2

[0030] Dissolve the compound of formula 2a (40g) in DMF (300mL), cool to 0-5°C, add 9.3g NaH (60%) in batches, stir for 20min, add bromomethyl methyl ether (MOMBr) (17.5g) dropwise, and react at room temperature for 2h. TLC detection is controlled to complete the reaction. Add 300ml water dropwise to quench the reaction, add 300ml ethyl acetate to extract and layer, and reduce the organic phase to dryness to obtain the title compound of formula 2, an oily substance, 42.0g.

[0031] Synthesis of compound of formula 3

[0032] Dissolve the compound of formula 3a (100 g), triethylamine (74.3 g), and DMAP (4.2 g) in 500 mL THF, cool to 0-10°C, dropwise add triisopropylsilyl chloride (TIPSCl) (105.5 g), stir at room temperature for 2 h, and monitor the reaction by TLC. Add 500 mL of water and 500 mL of dichloromethane, extract, and reduce the organic phase to dryness to obtain the title compound of formula 3, 150 g, as an oil.

[0033] Synthesis of compound of formula 4

[0034] Dissolve the compound of formula 2 (4.7 g) in anhydrous THF (46 mL), cool to below -70°C, add n-BuLi (7.2 mL, 2.5 M THF solution) dropwise, and keep warm for 30 min. Add a THF solution of the compound of formula 3 (4.6 g, 5 mL) dropwise, and continue to react for 30 min. Control the reaction by TLC. Add 20 mL of saturated NH4Cl solution dropwise, add 30 mL of ethyl acetate for extraction, concentrate the organic phase under reduced pressure to dryness, and purify by column chromatography to obtain the compound of formula 4 as an oil, 5.3 g.

[0035] Synthesis of compound of formula 5

[0036] The compound of formula 4 (3.0 g) was dissolved in ethyl acetate (30 mL), tetrabutylammonium fluoride (6 ml, 1 M THF solution) was added, and the reaction was carried out at room temperature for 30 min. 30 mL of water was added, and the extraction was carried out. The organic phase was decompressed to dryness to obtain the title compound of formula 5 as an oil, 1.5 g.

[0037] Synthesis of compound of formula 6

[0038] The compound of formula 5 (1.5 g) was dissolved in dichloromethane, trifluoroacetic acid (0.1 g) was added, Pd / C (10%, 0.15 g) was added, a H2 balloon was installed, and H2 was replaced twice. The reaction was stirred at room temperature overnight to obtain the title compound of formula 6.

[0039] 1HNMR (DMSO-d6, 400MHz) δ: 8.96 (s, 1H), 6.92 (d, 1H), 6.85 (d, 1H), 6.60 (s, 1H), 6. 45(s, 2H), 5.11(s, 2H), 3.79(s, 2H), 3.17~3.25(m, 1H), 2.08(s, 6H), 1.10(d, 6H).

[0040] Synthesis of compound of formula 8

[0041] The compound of formula 6 (11 g), the compound of formula 7 (11.3 g), and cesium carbonate (17.0 g) were dissolved in acetonitrile (50 mL), heated to 65° C. and reacted overnight. The reaction was monitored by TLC. The reaction solution was cooled to room temperature, filtered, and the filtrate was decompressed to dryness. The title compound of formula 8 was obtained by column chromatography as an oily substance (12 g).

[0042] 1HNMR (DMSO-d6, 400MHz) δ: 6.93 (d, 1H), 6.85 (d, 1H), 6.62 (s, 1H), 6.47 (s, 2H), 5.15 (s, 2H), 4.45 (m, 2H) , 4.01~4.06 (m, 4H), 3.81 (s, 2H), 3.31 (s, 3H), 3.16~3.25 (m, 1H), 2.08 (s, 6H), 1.19 (d, 6H), 1.10 (d, 6H).

[0043] Synthesis of compound of formula 9

[0044] Dissolve the compound of formula 8 (16 g) in dichloromethane (100 mL), add trimethylsilyl bromide (TMSBr) (22.0 g) dropwise, react at room temperature overnight, monitor the reaction by TLC, add 100 ml of water, extract, and reduce pressure to dryness to obtain the title compound of formula 9.

[0045] 1 HNMR (DMSO-d6, 400MHz) δ: 9.05 (s, 1H), 6.93 (d, 1H), 6.85 (d, 1H), 6.62 (s, 1H), 6. 47(s, 2H), 4.45(m, 2H), 3.81(s, 2H), 3.16~3.25(m, 1H), 2.08(s, 6H), 1.10(d, 6H).

[0046] 2. Synthesis of the target compound of formula 1

[0047] 2.1 HPLC detection conditions

[0048] In this embodiment, high performance liquid chromatography (HPLC) was used to monitor the reaction solution after the reaction was completed, wherein the HPLC analysis method is as follows:

[0049] Chromatographic conditions: the chromatographic column is a C18 column (ACE UltraCore2.5SuperC184.6*150mm); UV detector, wavelength 230nm; mobile phase A is 0.05% trifluoroacetic acid aqueous solution; mobile phase B is acetonitrile; flow rate 1.0ml / min; injection volume 5μl; diluent is acetonitrile; column temperature is 45°C; running time is 20min; post-running time is 5min; gradient elution is performed according to the table below.

[0050] Time (min) Mobile phase A (%) Mobile phase B (%) 0.00 50 50 0.20 50 50 3.00 35 65 8.00 35 65 10.00 0 100 20.00 0 100

[0051] 2.2 Synthesis method

[0052] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (28 mg, 0.1 eq.) was added, SOCl2 (0.82 g, 2.5 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, which was dissolved by adding 14 mL of dichloromethane for later use. The compound of formula 10 (0.717 g, 1 eq.) was dissolved in 10 ml of dichloromethane, TiCl4 (0.73 g, 1.0 eq.) was added dropwise at 0-10°C, and after the addition was complete, triethylamine (1.56 g, 4 eq.) was added dropwise at -20-10°C, and the mixture was kept warm for 10 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -30°C, and the mixture was reacted for 2 h at this temperature, and the reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC to show that the ratio of cis:trans was ≈5.5:1. The reaction solution was added with 10 ml of water to quench the reaction, and the organic phase was extracted and decompressed to dryness. The target compound of formula 1 (1.25 g, yield: 62.5%) was obtained by column chromatography.

[0053] 1 HNMR (400MHz, DMSO-d) δppm 1.10 (d, J=6.85Hz, 6H), 2.17 (s, 6H), 2.19-2.28 (m, 2H), 3.13 (dquin, J=13.75, 6.80, 6.80, 6.8 0, 6.80Hz, 1H), 3.82 (s, 2H), 4.39-4.46 (m, 1H), 4.46-4.52 (m, 2H), 4.56-4.64 (m, 1H), 5.76 (br d, J=10.03Hz, 1H), 6.42-6.51 (m, 1H), 6.62 (d, J=8.19Hz, 1H), 6.68-6.80 (m, 2H), 6.80-6.88 (m, 1H), 7.33-7.42 (m, 3H), 7.50 (s, 1H), 8.98 (s, 1H).

[0054] Example 2

[0055] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (140 mg, 0.5 eq.) was added, SOCl2 (1.64 g, 5.0 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL of dichloromethane was added to dissolve the oil for later use. The compound of formula 10 (0.86 g, 1.2 eq.) was dissolved in 10 ml of dichloromethane, TiCl4 (1.09 g, 1.5 eq.) was added dropwise at -10°C, and triethylamine (3.11 g, 8 eq.) was added dropwise at -20 to 10°C after the addition was complete, and the mixture was kept warm for 10 min. The obtained solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -20°C and reacted at this temperature for 2 hours. The reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC to show that the ratio of cis:trans was ≈3.0:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of formula 1 (1.1 g, yield: 55%).

[0056] Example 3

[0057] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (56 mg, 0.2 eq.) was added, SOCl2 (0.82 g, 2.5 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, which was dissolved by adding 14 mL of dichloromethane for standby use. The compound of formula 10 (0.86 g, 1.2 eq.) was dissolved in 10 ml of dichloromethane, TiCl4 (0.874 g, 1.2 eq.) was added dropwise at 0-5°C, and triethylamine (0.78 g, 2 eq.) was added dropwise at 0-5°C, and the mixture was kept warm for 10 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at 0°C, and the mixture was reacted at the same temperature for 2 h, and the reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC to show that the ratio of cis:trans was ≈3.2:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, and the organic phase was extracted. The organic phase was reduced to dryness under reduced pressure and purified by column chromatography to obtain the target compound of formula 1 (1.05 g, yield: 53%).

[0058] Example 4

[0059] The compound of formula 9 (1.4 g) was dissolved in tetrahydrofuran (14 ml), DMF (5.6 mg, 0.02 eq.) was added, SOCl2 (0.82 g, 2.5 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL of tetrahydrofuran was added to dissolve the oil for later use. The compound of formula 10 (0.72 g, 1.0 eq.) was dissolved in 10 ml of tetrahydrofuran, TiCl4 (0.874 g, 1.2 eq.) was added dropwise at 10-15°C, and triethylamine (0.97 g, 2.5 eq.) was added dropwise at 0-5°C, and the mixture was kept warm for reaction for 20 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40°C, and the reaction was continued for 2 h at the same temperature, and the reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC and showed that the ratio of cis:trans was ≈6:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, and the organic phase was extracted and decompressed to dryness. The target compound of formula 1 (1.3 g, yield: 65%) was obtained by column chromatography.

[0060] Example 5

[0061] The compound of formula 9 (1.4 g) was dissolved in 1,2-dichloroethane (14 ml), DMF (5.6 mg, 0.02 eq.) was added, oxalyl chloride (1.95 g, 4.0 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL 1,2-dichloroethane was added to dissolve the oil for later use. The compound of formula 10 (0.72 g, 1.0 eq.) was dissolved in 10 ml 1,2-dichloroethane, TiCl4 (0.874 g, 1.2 eq.) was added dropwise at 10-15°C, and triethylamine (1.17 g, 3.0 eq.) was added dropwise at 0-5°C, and the mixture was kept warm for reaction for 20 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40°C, and the reaction was carried out for 2 h at this temperature, and the reaction was monitored by TLC until the reaction no longer proceeded. The reaction solution was measured by HPLC and showed cis:trans ≈6.0:1 (HPLC determination method is the same as Example 1), 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of formula 1 (1.2 g, yield: 60%).

[0062] Example 6

[0063] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), and DMF (5.6 mg, 0.02 eq.) and triphosgene (2.28 g, 2.0 eq.) were added. The reaction was refluxed overnight. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11. 14 mL of dichloromethane was added to dissolve it for later use. The compound of formula 10 (0.79 g, 1.1 eq.) was dissolved in 10 ml of dichloromethane, and TiCl4 (0.874 g, 1.2 eq.) was added dropwise at 10-15°C. After the addition was completed, triethylamine (2.33 g, 6.0 eq.) was added dropwise at 0-5°C, and the reaction was kept warm for 20 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40°C, and the reaction was continued for 2 h at this temperature. The reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was measured by HPLC and showed that the ratio of cis:trans was ≈6.1:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, and the organic phase was extracted and decompressed to dryness. The target compound of formula 1 (1.2 g, yield: 60%) was obtained by column chromatography.

[0064] Example 7

[0065] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), and DMF (5.6 mg, 0.02 eq.) and triphosgene (2.28 g, 2.0 eq.) were added. The mixture was refluxed overnight. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11. 14 mL of dichloromethane was added to dissolve the oil for later use. The compound of formula 10 (0.72 g, 1.0 eq.) was dissolved in 10 ml of dichloromethane, and SnCl4 (1.0 g, 1.0 eq.) was added dropwise at 10-15°C. After the addition was completed, triethylamine (2.33 g, 6.0 eq.) was added dropwise at 0-5°C. The mixture was kept warm for 20 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -10°C, and the reaction was continued for 2 h at this temperature. The reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC and showed that the ratio of cis:trans was ≈2.8:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of Formula 1 (1.05 g, yield: 53%).

[0066] Example 8

[0067] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (5.6 mg, 0.02 eq.) was added, SOCl2 (0.82 g, 2.5 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily substance, the phosphonyl chloride intermediate 11, which was dissolved by adding 14 mL of dichloromethane for standby use. The compound of formula 10 (0.72 g, 1.0 eq.) was dissolved in 10 ml of dichloromethane, and FeCl3 (1.25 g, 2.0 eq.) was added dropwise at 10-15°C. After the addition was completed, triethylamine (0.97 g, 2.5 eq.) was added dropwise at 0-5°C, and the mixture was kept warm for reaction for 20 min. The resulting solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -50°C, and the reaction was continued for 2 h at the same temperature, and the reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC and showed that the ratio of cis:trans was ≈7.0:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of Formula 1 (0.9 g, yield: 45.5%).

[0068] In this embodiment, the last step of condensation reaction was carried out at -50°C. Due to the low reaction temperature, the reaction was incomplete and some raw materials were not completely converted into products. Therefore, although the reaction solution showed a high proportion of cis-products as determined by HPLC, the yield of the target compound of Formula 1 finally obtained was not further increased accordingly.

[0069] Example 9

[0070] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (140 mg, 0.5 eq.) was added, SOCl2 (1.64 g, 5.0 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL of dichloromethane was added to dissolve the oil for later use. The compound of formula 10 (0.86 g, 1.2 eq.) was dissolved in 10 ml of dichloromethane, TiCl4 (1.09 g, 1.5 eq.) was added dropwise at -10°C, and triethylamine (1.56 g, 4 eq.) was added dropwise at -20 to 10°C after the addition was complete, and the mixture was kept warm for 10 min. The obtained solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40°C and reacted at this temperature for 2 hours. The reaction was monitored by TLC until the reaction stopped. The reaction solution was determined by HPLC to show that the ratio of cis:trans was ≈6.0:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of formula 1 (1.3 g, yield: 65%).

[0071] Example 10

[0072] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (140 mg, 0.5 eq.) was added, SOCl2 (1.64 g, 5.0 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL of dichloromethane was added to dissolve the oil for later use. The compound of formula 10 (0.86 g, 1.2 eq.) was dissolved in 10 ml of dichloromethane, TiCl4 (1.09 g, 1.5 eq.) was added dropwise at -10°C, and triethylamine (1.56 g, 4 eq.) was added dropwise at -20 to 10°C after the addition was complete, and the mixture was kept warm for 10 min. The obtained solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -35°C and reacted at this temperature for 2 hours. The reaction was monitored by TLC until the reaction no longer proceeded. The reaction solution was determined by HPLC to show that the ratio of cis:trans was ≈5.7:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the target compound of formula 1 (1.2 g, yield: 60%).

[0073] Embodiment 11

[0074] Single crystal testing:

[0075] Instrument model: Micro-focus rotating target single crystal X-ray diffractometer, XtaLAB Synergy (007Mo).

[0076] Single crystal cultivation method: Take 1.0 g of the compound of formula 1 obtained in Example 1-10 with a purity higher than 99.0% and put it into a 50 ml sample bottle, dissolve it in 10 ml of ethyl acetate, add 10 ml of methyl tert-butyl ether to dissolve it, loosen the bottle mouth, and put it in a constant temperature box at 20°C for 10 days to obtain a single crystal.

[0077] The single crystal X-ray diffractometer was used to detect Figure 1 The X-ray single crystal diffraction pattern shown. The obtained single crystal is a compound of formula 1-methyl tert-butyl ether solvate, Figure 1 The stereo configuration of C7 and P1 is consistent with the structural formula of the compound of formula 1.

[0078] The test results are shown in Table 1 below:

[0079] Table 1. Crystallographic data and structural details determined

[0080]

[0081] Comparative Example 1

[0082] Add the compound of formula 9 (1.20 g), dicyclohexylcarbodiimide (DCC) (2.03 g), pyridine (5.72 g), and N,N-dimethylformamide (6 ml) to a 25 ml reaction bottle and stir at room temperature for 10 minutes. Add the compound of formula 10 (0.62 g) dropwise, and heat to 65°C for reaction. After the reaction is completed, add 1 ml of water to quench the reaction, and add 20 ml of dichloromethane to extract the reaction. The extract was tested by HPLC and showed that the ratio of cis:trans ≈1.7:1. The compound of formula 1 (0.25 g, yield: 15%) was obtained by column chromatography.

[0083] This example uses the method disclosed in Example 13 of patent application WO2006128055 to prepare the compound of formula 1. Similar to the results disclosed in the patent application, the stereoselectivity of the reaction to generate the cis product is poor and the yield is low.

[0084] Comparative Example 2

[0085] The compound of formula 1 was prepared according to the method of comparative example 1, wherein the types and amounts of the reactants of formula 9, formula 10, condensing agent and organic base, and the specific experimental results are shown in Table 2 below:

[0086] Table 2

[0087]

[0088] In this comparative example, the type and amount of the condensing agent and the organic base were changed, and the method of comparative example 1 was used to prepare the compound of formula 1. However, similar to the result of comparative example 1, the stereoselectivity of the cis product generated by the reaction was poor and the yield was low.

[0089] Comparative Example 3

[0090] The compound of formula 9 (1.4 g) was dissolved in dichloromethane (14 ml), DMF (5.6 mg, 0.02 eq.) was added, 80C12 (0.82 g, 2.5 eq.) was added dropwise, and the mixture was refluxed for overnight reaction. The reaction solution was decompressed to dryness to obtain an oily phosphonyl chloride intermediate 11, and 14 mL of dichloromethane was added to dissolve the oil for later use. The compound of formula 10 (0.72 g, 1.0 eq.) was dissolved in 10 ml of dichloromethane, and A1C13 (1.03 g, 2.0 eq.) was added dropwise at 10-15°C. After the addition was completed, triethylamine (1.56 g, 4 eq.) was added dropwise at 0-5°C, and the mixture was kept warm for reaction for 20 min. The obtained solution was added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40°C, and the reaction was continued for 2 h. The reaction was monitored by TLC until the reaction was no longer carried out. The reaction solution was determined by HPLC and showed that the ratio of cis:trans was ≈1.4:1 (HPLC determination method was the same as in Example 1). 10 ml of water was added to quench the reaction, extracted, the organic phase was decompressed to dryness, and column chromatography was performed to obtain the compound of formula 1 (0.1 g, yield: 5%).

[0091] This comparative example changes the type of Lewis acid, using Lewis acid AlCl3 to replace TiCl4, SnCl4 and / or FeCl3 of the present invention, however, the selectivity of the reaction to generate the cis product is poor and the yield is low. It can be seen that for the preparation of the cyclic phosphonate compound shown in Formula 1 of the present invention, the type of Lewis acid added has a great influence on the stereoselectivity and yield of the reaction.

Claims

1. A method for preparing a cyclic phosphonate compound represented by formula 1, comprising the following steps: (1) reacting the compound represented by formula 9 with a chlorinating agent to obtain a phosphonyl chloride intermediate 11, which is then dissolved in an organic solvent to obtain a solution of the phosphonyl chloride intermediate 11 for later use; (2) dissolving the compound represented by formula 10 in an organic solvent, adding a Lewis acid and a base in sequence, stirring and reacting, and adding the resulting reaction solution to the solution of the phosphonyl chloride intermediate 11 described in step (1) to react, thereby obtaining a cyclic phosphonate compound represented by formula 1, wherein the Lewis acid is TiCl4, SnCl4 and / or FeCl3, 2. The preparation method according to claim 1, wherein The organic solvent is dichloromethane, 1,2-dichloroethane and / or tetrahydrofuran; and / or the chlorination agent is thionyl chloride, oxalyl chloride and / or triphosgene; preferably, in step (1), the molar ratio of the chlorination agent to the compound shown in formula 9 is 2:1 to 5:

1.

3. The preparation method according to claim 1 or 2, wherein In the step (2), the molar ratio of the compound represented by formula 10 to the compound represented by formula 9 is 1.0:1 to 1.2:

1.

4. The preparation method according to any one of claims 1 to 3, wherein The molar ratio of the Lewis acid to the compound represented by Formula 10 is 1:1 to 2:

1.

5. The preparation method according to any one of claims 1 to 4, wherein The base is an organic base, preferably triethylamine; preferably, the molar ratio of the triethylamine to the compound represented by Formula 10 is 1.5:1 to 8:

1.

6. The preparation method according to any one of claims 1 to 5, wherein In the step (1), the chlorination reagent is added dropwise to the compound represented by formula 9 at 15-25°C, and the reaction is carried out at 35-85°C.

7. The preparation method according to any one of claims 1 to 6, wherein In the step (2), the Lewis acid is added dropwise at -10 to 15°C, and the base is added dropwise at -20 to 10°C. Preferably, after the Lewis acid and the base are added in sequence, the reaction is stirred for 10 to 60 minutes.

8. The preparation method according to any one of claims 1 to 7, wherein In the step (2), the reaction solution is added dropwise to the solution of the phosphonyl chloride intermediate 11 at -50 to 0°C and the reaction is carried out at -50 to 0°C.

9. The preparation method according to any one of claims 1 to 7, wherein In the step (2), the reaction solution is added dropwise to the solution of the phosphonyl chloride intermediate 11 at -40 to -30°C and the reaction is carried out at -40 to -30°C.

10. The preparation method according to any one of claims 1 to 9, wherein In the step (1), the compound represented by the formula 9 is reacted with the chlorination reagent in the presence of N,N-dimethylformamide. Preferably, the molar ratio of the N,N-dimethylformamide to the compound represented by the formula 9 is 0.02:1 to 0.5:1.